Yes.Saying that end of year Phase III WAMD will start???
Also saying that the science in DME is good for a Phase III in DME.
Phase II DME showed efficacy. They can go back to look at responders and non-responders.
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME, page-26
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
-0.020(3.54%) |
Mkt cap ! $667.8M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.0¢ | 53.0¢ | $335.6K | 616.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 23375 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 10971 | 8 |
View Market Depth
| Last trade - 13.27pm 04/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |